Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CDLX
stocks logo

CDLX

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2026Q1
56.32M
-23.89%
-0.150
-0%
50.25M
-18.81%
-0.135
-35.71%
Estimates Revision
The market is revising Downward the revenue expectations for Cardlytics, Inc. (CDLX) for FY2025, with the revenue forecasts being adjusted by -1.68% over the past three months. During the same period, the stock price has changed by 29.80%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.68%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-7.76%
In Past 3 Month
Stock Price
Go Up
up Image
+29.80%
In Past 3 Month
Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is 1.63 USD with a low forecast of 1.50 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is 1.63 USD with a low forecast of 1.50 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
1 Sell
Hold
Current: 1.210
sliders
Low
1.50
Averages
1.63
High
2.00
Current: 1.210
sliders
Low
1.50
Averages
1.63
High
2.00
Lake Street
Hold
downgrade
$3
2025-05-08
Reason
Lake Street
Price Target
$3
2025-05-08
downgrade
Hold
Reason
Needham
Kyle Peterson
Hold
Reiterates
n/a
2025-03-13
Reason
Needham
Kyle Peterson
Price Target
n/a
2025-03-13
Reiterates
Hold
Reason
Evercore ISI Group
Mark Mahaney
Hold
Maintains
$4 → $3
2025-03-13
Reason
Evercore ISI Group
Mark Mahaney
Price Target
$4 → $3
2025-03-13
Maintains
Hold
Reason
Lake Street
Jacob Stephan
Hold
Maintains
$5 → $3
2025-03-13
Reason
Lake Street
Jacob Stephan
Price Target
$5 → $3
2025-03-13
Maintains
Hold
Reason
Needham
Kyle Peterson
Hold
Reiterates
n/a
2025-01-17
Reason
Needham
Kyle Peterson
Price Target
n/a
2025-01-17
Reiterates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Cardlytics Inc (CDLX.O) is -3.27, compared to its 5-year average forward P/E of -15.33. For a more detailed relative valuation and DCF analysis to assess Cardlytics Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-15.33
Current PE
-3.27
Overvalued PE
54.23
Undervalued PE
-84.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-125.08
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
273.80
Undervalued EV/EBITDA
-523.96

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.73
Current PS
0.00
Overvalued PS
8.56
Undervalued PS
-1.10
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 361.26% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CDLX News & Events

Events Timeline

(ET)
2025-11-07
08:45:02
Significant Borrowing Rate Hikes Among Liquid Assets
select
2025-11-05 (ET)
2025-11-05
17:15:06
Cardlytics Projects Q4 Revenue Between $51.1M and $59.1M, Below Consensus Estimate of $59.07M
select
2025-11-05
17:13:55
Cardlytics announces Q3 adjusted EPS of 7 cents, falling short of consensus estimate of 15 cents.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
11-11NASDAQ.COM
Everything You Should Know About Cardlytics (CDLX) Upgrade to Buy Rating

  • Zacks Rank Upgrade: Cardlytics (CDLX) has been upgraded to a Zacks Rank #2 (Buy), indicating a positive outlook on its earnings estimates, which could lead to an increase in its stock price.

  • Earnings Estimate Revisions: The Zacks Consensus Estimate for Cardlytics has risen by 63.2% over the past three months, reflecting a strong correlation between earnings estimate revisions and near-term stock movements.

  • Zacks Rating System: The Zacks Rank system classifies stocks based on earnings estimates, with only the top 20% receiving a "Buy" or "Strong Buy" rating, suggesting Cardlytics is well-positioned for potential market-beating returns.

  • Investment Opportunities: The article highlights several stocks with high growth potential, encouraging investors to consider lesser-known opportunities that may yield significant returns.

[object Object]
Preview
9.5
11-06NASDAQ.COM
Transcript of Cardlytics (CDLX) Earnings Call for Q3 2025
  • Author's Perspective: The views and opinions presented are solely those of the author.
  • No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
[object Object]
Preview
8.0
10-02Newsfilter
Cardlytics Unveils Job Cuts in Effort to Realign Organization and Reduce Costs

  • Cost Savings Initiative: Cardlytics Inc. announced a cost savings initiative that includes a workforce reduction of approximately 120 employees, or 30% of its total workforce, to optimize its cost structure and focus on critical business priorities.

  • Financial Impact: The company expects to incur $2.3 million in severance expenses and aims to achieve annualized cash savings of at least $26 million, while remaining committed to positive adjusted EBITDA for 2025 and 2026.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Cardlytics Inc (CDLX) stock price today?

The current price of CDLX is 1.21 USD — it has decreased -1.63 % in the last trading day.

arrow icon

What is Cardlytics Inc (CDLX)'s business?

Cardlytics, Inc. is a provider of a digital advertising platform. Through the Cardlytics platform, its financial media network, marketers deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States and the United Kingdom. Cardlytics platform helps marketers find new customers that are active in their category but not shopping with them, or to grow their business with existing customers. Cardlytics platform provides its marketers with a scalable solution for driving customer loyalty and engagement, whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting the performance of their campaigns to attributing incentives to each of its partners customers. The Bridg platform is a customer data platform that utilizes POS data from its merchant data partners, including product-level purchase data.

arrow icon

What is the price predicton of CDLX Stock?

Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is 1.63 USD with a low forecast of 1.50 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Cardlytics Inc (CDLX)'s revenue for the last quarter?

Cardlytics Inc revenue for the last quarter amounts to 52.03M USD, decreased -22.41 % YoY.

arrow icon

What is Cardlytics Inc (CDLX)'s earnings per share (EPS) for the last quarter?

Cardlytics Inc. EPS for the last quarter amounts to -1.36 USD, decreased -53.10 % YoY.

arrow icon

What changes have occurred in the market's expectations for Cardlytics Inc (CDLX)'s fundamentals?

The market is revising Downward the revenue expectations for Cardlytics, Inc. (CDLX) for FY2025, with the revenue forecasts being adjusted by -1.68% over the past three months. During the same period, the stock price has changed by 29.80%.
arrow icon

How many employees does Cardlytics Inc (CDLX). have?

Cardlytics Inc (CDLX) has 454 emplpoyees as of December 05 2025.

arrow icon

What is Cardlytics Inc (CDLX) market cap?

Today CDLX has the market capitalization of 65.41M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free